Key points are not available for this paper at this time.
May support NLR for CVD risk stratification; leaves open whether it guides therapy or improves outcomes.
Response to: Akhtar MS, Bhat T, Teli S et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev. Cardiovasc. Ther. 11(1), 55–59 (2013).We read the article ‘Neutrophil...
No takes yet. Share an insight, caveat, or question.
Balta et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: